U.S. Capital Wealth Advisors’s Aveanna Healthcare AVAH Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,000	Closed	-$3.12K	–	699
2022 Q4	$3.12K	Buy	+4,000	New	+$4.18K	﹤0.01%	1450

Other funds holding AVAH

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

JHWEPV

J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

Littlejohn & Co Greenwich, Connecticut $78.6M AUM 1.93% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

U.S. Capital Wealth Advisors's AVAH Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Aveanna Healthcare (AVAH) in Q1 2023, closing a stake of 4,000 shares — an estimated $3.12K sold.

U.S. Capital Wealth Advisors first reported a position in AVAH in Q4 2022 and held it in 1 quarter. The position peaked at $3.12K in Q4 2022. 68 funds tracked by Wall St. Rank hold AVAH as of Q1 2023.

U.S. Capital Wealth Advisors reported no remaining Aveanna Healthcare position as of Q1 2023 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 4,000 Aveanna Healthcare shares in Q1 2023, an estimated $3.12K.
U.S. Capital Wealth Advisors first reported a position in Aveanna Healthcare in Q4 2022 and held it in 1 quarter.
U.S. Capital Wealth Advisors's Aveanna Healthcare position peaked at $3.12K in Q4 2022.
68 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.